Vuornos Kaisa, Björninen Miina, Talvitie Elina, Paakinaho Kaarlo, Kellomäki Minna, Huhtala Heini, Miettinen Susanna, Seppänen-Kaijansinkko Riitta, Haimi Suvi
1 Adult Stem Cells, BioMediTech, University of Tampere , Tampere, Finland .
2 Science Center, Tampere University Hospital , Tampere, Finland .
Tissue Eng Part A. 2016 Mar;22(5-6):513-23. doi: 10.1089/ten.tea.2015.0276. Epub 2016 Feb 26.
Growing number of musculoskeletal defects increases the demand for engineered tendon. Our aim was to find an efficient strategy to produce tendon-like matrix in vitro. To allow efficient differentiation of human adipose stem cells (hASCs) toward tendon tissue, we tested different medium compositions, biomaterials, and scaffold structures in preliminary tests. This is the first study to report that medium supplementation with 50 ng/mL of growth and differentiation factor-5 (GDF-5) and 280 μM l-ascorbic acid are essential for tenogenic differentiation of hASCs. Tenogenic medium (TM) was shown to significantly enhance tendon-like matrix production of hASCs compared to other tested media groups. Cell adhesion, proliferation, and tenogenic differentiation of hASCs were supported on braided poly(l/d)lactide (PLA) 96l/4d copolymer filament scaffolds in TM condition compared to foamed poly(l-lactide-co-ɛ-caprolactone) (PLCL) 70L/30CL scaffolds. A uniform cell layer formed on braided PLA 96/4 scaffolds when hASCs were cultured in TM compared to maintenance medium (MM) condition after 14 days of culture. Furthermore, total collagen content and gene expression of tenogenic marker genes were significantly higher in TM condition after 2 weeks of culture. The elastic modulus of PLA 96/4 scaffold was more similar to the elastic modulus reported for native Achilles tendon. Our study showed that the optimized TM is needed for efficient and rapid in vitro tenogenic extracellular matrix production of hASCs. PLA 96/4 scaffolds together with TM significantly stimulated hASCs, thus demonstrating the potential clinical relevance of this novel and emerging approach to tendon injury treatments in the future.
肌肉骨骼缺陷数量的不断增加,使得对工程化肌腱的需求日益增长。我们的目标是找到一种在体外生产类肌腱基质的有效策略。为了使人类脂肪干细胞(hASC)有效地分化为肌腱组织,我们在初步试验中测试了不同的培养基成分、生物材料和支架结构。这是第一项报道培养基中添加50 ng/mL生长分化因子5(GDF-5)和280 μM l-抗坏血酸对hASC向肌腱分化至关重要的研究。与其他测试的培养基组相比,肌腱诱导培养基(TM)显示出能显著增强hASC的类肌腱基质生成。在TM条件下,与泡沫聚(l-丙交酯-共-ε-己内酯)(PLCL)70L/30CL支架相比,编织聚(l/d)丙交酯(PLA)96l/4d共聚物长丝支架能支持hASC的细胞黏附、增殖和肌腱分化。在TM中培养hASC时,与培养14天后的维持培养基(MM)条件相比,编织PLA 96/4支架上形成了均匀的细胞层。此外,培养2周后,TM条件下的总胶原蛋白含量和肌腱标记基因的表达显著更高。PLA 96/4支架的弹性模量与天然跟腱报道的弹性模量更相似。我们的研究表明,高效快速地在体外生成hASC肌腱细胞外基质需要优化的TM。PLA 96/4支架与TM一起能显著刺激hASC,从而证明了这种新兴方法在未来肌腱损伤治疗中的潜在临床应用价值。